Endpoint definition
↥Filter registries Inpat., Oupat., Death
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
Extra metadata
lymphoma: A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.
Filter registries Inpat., Oupat., Death
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
Extra metadata
List of similar endpoints to Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
All | Female | Male | |
---|---|---|---|
Number of individuals | 145 | 69 | 76 |
Unadjusted prevalence (%) | 0.06 | 0.05 | 0.07 |
Mean age at first event (years) | 51.54 | 50.70 | 52.30 |
Follow-up | Absolute risk | HR [95% CI] | p | N |
---|---|---|---|---|
1998–2019 | - | - | - | - |
15 years | - | - | - | - |
5 years | - | - | - | - |
1 year | - | - | - | - |
Index endpoint: CD2_PRIMARY_LYMPHOID_HEMATOPOIETIC_NAS – Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
GWS hits: 0
before Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
after Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
Loading survival analyses plot
Loading survival analyses table